3-Iodo-1H-pyrazole-4-carboxylic acid ethyl ester

CAS : 827316-43-8

Ref. 3D-FI74684

Informations sur le produit

• Nom: 3-Iodo-1H-pyrazole-4-carboxylic acid ethyl ester

Description

Begaestat is a novel, orally active, small-molecule inhibitor of chymotrypsin-like activity in the human proteasome. It has been shown to be effective in inhibiting tumor cell growth and metastasis in animal models and has demonstrated clinical activity in phase I clinical trials. Begaestat inhibits the production of methylthioadenosine (MTA), which is an endogenous metabolite that can inhibit cancer cells. MTA inhibits the production of protein, leading to cell death by inhibiting protein synthesis and DNA replication. Begaestat also binds to a synthetic substrate that resembles the arginine site on the proteasome, thereby preventing the formation of an enzyme-substrate complex and inhibiting chymotrypsin-like activity.

• Marque: Biosynth

Propriétés chimiques

• Degré de pureté: Min. 95%